Joseph Douglas Lyon - 22 Nov 2024 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Chief Accounting & Technology Officer
Signature
/s/ Joseph Douglas Lyon
Issuer symbol
CORT
Transactions as of
22 Nov 2024
Net transactions value
-$80,032
Form type
4
Filing time
26 Nov 2024, 18:13:10 UTC
Previous filing
05 Sep 2024
Next filing
04 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORT Common Stock Sale $80,032 -1,411 -14% $56.72 8,494 22 Nov 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 460 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, 507 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, and 1,232 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Remarks:

Chief Accounting & Technology Officer